Published in Virology on December 01, 1987
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J (1988) 2.84
Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J (1994) 2.03
Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol (1991) 2.00
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol (1989) 1.85
Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J (1991) 1.72
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
Host range determinants located on the interior of the poliovirus capsid. EMBO J (1991) 1.60
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol (1995) 1.47
Cleavage of VP1 and modification of antigenic site 1 of type 2 polioviruses by intestinal trypsin. J Virol (1988) 1.16
Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors. J Virol (1997) 1.13
Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog (2012) 1.08
Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol (1991) 1.03
Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles. J Virol (1990) 0.86
Cloned poliovirus complementary DNA is infectious in mammalian cells. Science (1981) 12.50
Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc Natl Acad Sci U S A (1981) 12.00
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08
Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region. Mol Cell Biol (1988) 4.97
Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J Virol (1986) 4.91
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell (1990) 3.70
Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA. J Mol Biol (1981) 3.18
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA. Virology (1986) 2.95
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol (1990) 2.77
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A (1989) 2.65
Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A (2000) 2.64
Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J Virol (1989) 2.46
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol (1987) 2.36
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med (1992) 2.28
Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J (1994) 2.03
Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol (1991) 2.00
Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology (1993) 1.97
Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J Virol (1992) 1.94
Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5' noncoding region. J Virol (1988) 1.85
Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J Virol (1989) 1.85
Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods (1993) 1.82
In vitro synthesis of infectious poliovirus RNA. Proc Natl Acad Sci U S A (1985) 1.78
Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J Virol (1989) 1.77
Transformation of a human poliovirus receptor gene into mouse cells. Proc Natl Acad Sci U S A (1986) 1.68
Poliovirus spreads from muscle to the central nervous system by neural pathways. J Infect Dis (1992) 1.66
Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol (1992) 1.65
Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol (1995) 1.63
Parkinson's disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology (1987) 1.61
Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication. J Virol (1994) 1.61
Host range determinants located on the interior of the poliovirus capsid. EMBO J (1991) 1.60
Poliovirus mutants resistant to neutralization with soluble cell receptors. Science (1990) 1.52
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol (1995) 1.47
Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol (2001) 1.46
Two distinct binding affinities of poliovirus for its cellular receptor. J Biol Chem (2000) 1.45
Fetal rat brain damage caused by maternal seizure activity: prevention by magnesium sulfate. Am J Obstet Gynecol (1999) 1.45
The polio eradication effort: should vaccine eradication be next? Science (1997) 1.44
Influenza B virus genome: assignment of viral polypeptides to RNA segments. J Virol (1979) 1.43
Cold-adapted poliovirus mutants bypass a postentry replication block. J Virol (1997) 1.42
The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol (1999) 1.38
A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J Virol (1994) 1.37
Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions. Mol Cell Biol (2000) 1.35
Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol (1990) 1.34
Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis. Neurology (2001) 1.32
Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase. J Virol (1986) 1.30
Attenuating mutations in the poliovirus 5' untranslated region alter its interaction with polypyrimidine tract-binding protein. J Virol (1997) 1.29
A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol (1992) 1.25
Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol (1989) 1.23
Tumors of the choroid plexus in children. Neurosurgery (1989) 1.12
The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery (1991) 1.04
Mutational analysis of the cellular receptor for poliovirus. J Virol (1991) 1.04
Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J Virol (1997) 1.02
Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys (1999) 0.96
An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures. J Virol (2000) 0.95
Isolation of influenza C virus recombinants. J Virol (1979) 0.95
Intravascular papillary endothelial hyperplasia arising within a posteroinferior cerebellar artery aneurysm: case report and review of the literature. Neurosurgery (2000) 0.94
Clonal analysis of gliomas. Hum Pathol (1997) 0.93
Uncal herniation secondary to bacterial meningitis in a newborn. Pediatr Neurol (1992) 0.93
Genetic structure and genetic variation of influenza viruses. Philos Trans R Soc Lond B Biol Sci (1980) 0.92
Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma. Cancer Genet Cytogenet (1992) 0.90
Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Case report with angiographic and pathological studies. Stroke (1995) 0.89
CD44 is not required for poliovirus replication. J Virol (1997) 0.88
Pattern of undermethylation of the major satellite DNA of mouse sperm. Nucleic Acids Res (1985) 0.88
Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2. Virology (1997) 0.88
Seizures in children with supratentorial astroglial neoplasms. Pediatr Neurosurg (1994) 0.87
Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology (2003) 0.86
Spinal cord sarcoidosis: a diagnostic dilemma. Neurol Res (2001) 0.85
The change in patterns of relapse in medulloblastoma. Cancer (1991) 0.84
Clival chondroma in a child with Ollier's disease. Case report. Pediatr Neurosurg (1992) 0.83
Magnesium sulfate protection of fetal rat brain from severe maternal hypoxia. Obstet Gynecol (2000) 0.83
Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection. J Virol (1991) 0.82
Arteritis and fatal subarachnoid hemorrhage complicating occult Candida meningitis: unusual presentation in pediatric acquired immunodeficiency syndrome. Arch Pathol Lab Med (1998) 0.80
Construction of an infectious cDNA clone of echovirus 6. Virus Res (1992) 0.80
Lack of association between carotid plaque hematoma and ischemic cerebral symptoms. Stroke (1987) 0.79
Neuropathologic findings in a case of OFDS type VI (Váradi syndrome). Am J Med Genet (1998) 0.79
Intrauterine-onset myoclonic encephalopathy associated with cerebral cortical dysgenesis. J Child Neurol (1993) 0.79
Characterization of mouse lines transgenic with the human poliovirus receptor gene. Microb Pathog (1998) 0.79
Evaluation of expanded polytetrafluoroethylene (ePTFE) versus polydioxanone (PDS) for the repair of dura mater defects. Neurol Res (1999) 0.78
Myopathy with muscle spindle excess: A new congenital neuromuscular syndrome? Muscle Nerve (2001) 0.78
Analysis of p53 gene mutations in human gliomas by polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Diagn Mol Pathol (1994) 0.78
Differences in the UV-crosslinking patterns of the poliovirus 5'-untranslated region with cell proteins from poliovirus-susceptible and -resistant tissues. Virology (1997) 0.77
Childhood onset oculopharyngeal muscular dystrophy. Pediatr Neurol (1992) 0.76
Serotonin-binding glycoprotein of rat platelets. J Cell Sci (1983) 0.76
Arthrogryposis multiplex congenita with posterior column degeneration and peripheral neuropathy: a case report. Clin Neuropathol (1993) 0.76
Magnetic resonance imaging of intercranial plasmocytic granuloma. Skull Base Surg (1999) 0.75
Viral sequences required for neurovirulence of poliovirus. Bioessays (1986) 0.75
Muscle and nerve biopsy in the evaluation of neuromuscular disorders: the surgeon's perspective. J Pediatr Surg (1999) 0.75
201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol (1991) 0.75
Poliovirus vaccines. Biotechnology (1992) 0.75
Nucleolar organizer regions in optic gliomas. Brain (1993) 0.75
The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Am J Clin Pathol (1993) 0.75
Familial infantile olivopontocerebellar atrophy. Pediatr Neurol (1995) 0.75
Studying poliovirus with infectious cloned cDNA. Rev Infect Dis (1984) 0.75
Fetal rat brain injury: effect of transient maternal hypoxemia. Fetal Diagn Ther (1997) 0.75
Intracranial melanotic neuroectodermal tumor of infancy: two case reports. Surg Neurol (1992) 0.75
Ontogeny of recurrent hydrocephalus: presentation in three fetuses in one consanguineous family. Fetal Diagn Ther (1999) 0.75